The purchase fits Merck's plans to partly focus on acute care in hospitals. Cubist's lead drugs treats infections caused by drug-resistant bacteria. Fred Katayama reports.
01:30
00:47
00:46
01:01
01:18
01:32
01:26
01:37
01:10
01:33
01:30
01:53
01:43
01:15
00:52
02:03
01:27
00:12
02:19
00:46
01:30
01:04
02:14
01:06
02:22
01:06
00:52
02:17
02:04
02:15
01:17
01:40
01:04
01:24
01:15
01:51
01:44
01:44
03:02
03:07
00:46
00:42
01:37
01:33
01:43
00:47
01:04
00:46
01:18
00:45
00:12
01:07
00:46
01:16
01:39
01:08
00:45
01:27
01:07
01:16
00:47
01:22
01:01
01:03
01:21
01:05
01:13
01:17
00:56
01:00
01:49
02:05
00:56
03:04
00:40
01:02
01:37
02:25
01:18
02:56
01:18
00:59
02:49
02:19
02:19
01:59
00:49
00:38
02:34
02:10
01:46
00:54
02:09
02:09
00:58
02:37
01:11
01:40
01:22
02:09